Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

NCT00345826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: dasatinib

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]